A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Terminated · Phase 3 · NCT03464097
Conditions: Crohn Disease
At a glance
- Research payments reported, 2025
- $234,490
- U.S. investigators named
- 26
- Sites paid
- 25
- Planned or actual enrollment
- 550
About the trial
- Sponsor
- Celgene
- Tested
- Ozanimod (drug), Placebo (other)
- Dates
- Started 2018-06-27; completion 2024-10-03
- Results posted
- Yes
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
From ClinicalTrials.gov, last updated 2025-10-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Celgene Corporation reported $234,490 in research payments for this study in 2025 (26 payments).
Products named: Zeposia
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Hyun S. Kim, MD Gastroenterology · San Diego, CA
- Jatinder S. Pruthi, M.D. Gastroenterology · Lancaster, CA
- Deborah D. Proctor, MD Gastroenterology · New Haven, CT
- Salam F. Zakko, MD Gastroenterology · Bristol, CT
- Ammar Hemaidan, MD Gastroenterology · Port Orange, FL
- Angela K. Pham, M.D. Gastroenterology · Gainesville, FL
- Jennifer L. Seminerio-diehl, MD Gastroenterology · Orlando, FL
- Heba N. Iskandar, M.D. Gastroenterology · Atlanta, GA
- David B. Rausher, M.D. Specialist · Decatur, GA
- Jessica R. Allegretti, M.D. Gastroenterology · Boston, MA
- Abbas H. Rupawala, M.D. Gastroenterology · Worcester, MA
- Kenolisa C. Onwueme, M.D., PH.D. Gastroenterology · Baltimore, MD
- Alyssa M. Parian, MD Gastroenterology · Baltimore, MD
- Alan F. Cutler, MD Gastroenterology · Farmington Hills, MI
- Parakkal Deepak, MD Gastroenterology · Saint Louis, MO
- Angela Hira, DO Gastroenterology · Raleigh, NC
- Nilesh I. Lodhia, MD Gastroenterology · Charlotte, NC
- Michael J. Digiovanna, D.O. Internal Medicine · North Massapequa, NY
- Randy S. Longman, MD / PHD Gastroenterology · New York, NY
- Keith Sultan, MD Gastroenterology · Manhasset, NY
- Arun Swaminath, M.D. Gastroenterology · New York, NY
- Lisa A. Mueller, MD Gastroenterology · Providence, RI
- Erin M. Forster, M.D. Gastroenterology · Charleston, SC
- Jessica B. Johnson, MD Gastroenterology · Salt Lake City, UT
- Larry E. Clark JR., M.D. Gastroenterology · Lynchburg, VA
- Frances J. Jones, M.D. Gastroenterology · Williamsburg, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Gastroenterology Associates of Central Virginia $42,556
- Texas Digestive Disease Consultants Southlake $41,812
- Medical University of South Carolina $30,925
- Weill Medical College of Cornell University $12,875
- Medical Associates Research Group, Inc $12,250
- Biomedical Research Alliance of New York, Llc $11,992
- Johns Hopkins Office of Research Administration $10,385
- Metro Comprehensive Physical and Aquatic Therapy $9,500
- Advanced Medical Research Center $8,715
- Carolinas Medical Center-Northeast, NC $8,165
- Atlanta Center for Gastroenterology, PC $6,144
- University of Utah Hospital and Clinics, UT $5,814
- Tidewater Physicians Multispecialty Group PC $4,250
- Emory University Hospital, GA $3,770
- Washington University $3,720
- Woodholme Gastroenterology Associates $3,300
- Lee Daeyeol Mms $3,250
- Revival Research Institute, Inc $3,000
- Connecticut Clinical Research Institute Llc $2,500
- University of Florida Board of Trustees $2,366
- M3 Wake Research $2,050
- Brigham and Womens Physicians Organization $2,000
- Om Research Llc $2,000
- University of Massachusetts School of Medicine $650
- University of South Florida $501
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.